Nordic Life Science 1
UPCOMING EVENTS NORDIC LIFE SCIENCE NORDIC LIFE S
CIENCE UPCOMING EVENTS INSPIRING LIFE SCIENCE BUSINESS AND INNOVATION T E X T by M AL IN O T M ANI 19-21 AUGUST 2020: THE SWEDISH-AMERICAN LIFE SCIENCE SUMMIT he main theme of the conference is based upon “Strategies Trends and TechnoloWWW.SALSS.COM Barbro Ehnbom, the founder of SALSS gies for Drug Discovery and toxicology”. The conference is a multidisciplinary 2-day program with the participation of members from all around the world. The program displays an exhibition of a wide range of sessions involving workshops, keynote speeches, young research forums (YRF), e-posters, oral and poster presentations from professionals of pharmaceutical science. It provides the participants the opportunity to share their expertise and expert knowledge on pharmacology pharmaceutics, medicinal chemistry, drug discovery, future advances, next-generation sequencing, drug safety and also new advanced strategies involving bioavailability and bioequivalence research. 13–14 JULY 2020: DRUG DISCOVERY & TOXICOLOGY The 7th International Conference on Drug Discovery and Toxicology is planned to be held in Helsinki, Finland. The Swedish-American Life Science Summit (SALSS) features interesting topics, exciting speakers, great opportunities for collaboration and new, positive energy. HIS BY INVITATION ONLY conference brings together some of the most renowned life science executives, scientists, entrepreneurs and investors. The aim is to build strategic and collaborative relationships between academia, industry and financers thus enhancing life science business. The traditional event, held annually over three days in late August in Stockholm, includes top-notch speakers, high-level panel discussions, presentations by successful and promising companies, as well as exhibiting specially selected start-up companies operating within life science. SALSS also offers opportunities for one-to-one meetings and networking. The 2020 theme will be Gene & Cell Therapy and Sustainability. Gene and cell therapy is starting to revolutionize several diseases, not only cancer, but in order to reach the full potential of this therapy it is essential that the legal framework follows the development and does not slow it down, and that the costs decrease. DRUGCHEMISTRY.PHARMACEUTICALCONFERENCES.COM 100 NORDICLIFESCIENCE.ORG PHOTO JENNY ÖHMAN